195 related articles for article (PubMed ID: 35505353)
1. Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
Livingstone SJ; Guthrie B; Donnan PT; Thompson A; Morales DR
BMC Med; 2022 May; 20(1):152. PubMed ID: 35505353
[TBL] [Abstract][Full Text] [Related]
2. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
[TBL] [Abstract][Full Text] [Related]
3. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
[TBL] [Abstract][Full Text] [Related]
4. Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study.
Livingstone SJ; Guthrie B; McMinn M; Eke C; Donnan PT; Morales DR
Lancet Healthy Longev; 2023 Jan; 4(1):e43-e53. PubMed ID: 36610448
[TBL] [Abstract][Full Text] [Related]
5. External validation of the QLifetime cardiovascular risk prediction tool: population cohort study.
Livingstone S; Morales DR; Fleuriot J; Donnan PT; Guthrie B
BMC Cardiovasc Disord; 2023 Apr; 23(1):194. PubMed ID: 37061672
[TBL] [Abstract][Full Text] [Related]
6. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
Parsons RE; Liu X; Collister JA; Clifton DA; Cairns BJ; Clifton L
Heart; 2023 Oct; 109(22):1690-1697. PubMed ID: 37423742
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
8. Stroke risk in older British men: Comparing performance of stroke-specific and composite-CVD risk prediction tools.
Ahmed A; Ambler G; Pinto Pereira SM; Lennon L; Papacosta O; Whincup P; Wannamethee G
Prev Med Rep; 2023 Feb; 31():102098. PubMed ID: 36820364
[TBL] [Abstract][Full Text] [Related]
9. Sex inequalities in cardiovascular risk prediction.
Elliott J; Bodinier B; Whitaker M; Wada R; Cooke G; Ward H; Tzoulaki I; Elliott P; Chadeau-Hyam M
Cardiovasc Res; 2024 Jun; ():. PubMed ID: 38833617
[TBL] [Abstract][Full Text] [Related]
10. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
11. Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank.
Tseng RMWW; Rim TH; Shantsila E; Yi JK; Park S; Kim SS; Lee CJ; Thakur S; Nusinovici S; Peng Q; Kim H; Lee G; Yu M; Tham YC; Bakhai A; Leeson P; Lip GYH; Wong TY; Cheng CY
BMC Med; 2023 Jan; 21(1):28. PubMed ID: 36691041
[TBL] [Abstract][Full Text] [Related]
12. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
[TBL] [Abstract][Full Text] [Related]
13. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus.
Mu X; Wu A; Hu H; Zhou H; Yang M
Front Endocrinol (Lausanne); 2022; 13():1077632. PubMed ID: 36518244
[TBL] [Abstract][Full Text] [Related]
14. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population.
Livingstone SJ; Morales DR; McMinn M; Eke C; Donnan P; Guthrie B
BMJ Med; 2022; 1(1):e000316. PubMed ID: 36936595
[TBL] [Abstract][Full Text] [Related]
15. Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged ≥65 years.
Cooper H; Wells S; Mehta S
Int J Epidemiol; 2022 May; 51(2):604-614. PubMed ID: 34109395
[TBL] [Abstract][Full Text] [Related]
16. Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes.
Huang Z; Klaric L; Krasauskaite J; Khalid W; Strachan MWJ; Wilson JF; Price JF
Eur J Prev Cardiol; 2023 Sep; 30(12):1255-1262. PubMed ID: 37172216
[TBL] [Abstract][Full Text] [Related]
17. Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar.
Li Y; Sperrin M; Ashcroft DM; van Staa TP
BMJ; 2020 Nov; 371():m3919. PubMed ID: 33148619
[TBL] [Abstract][Full Text] [Related]
18. A cardiovascular risk prediction model for older people: Development and validation in a primary care population.
van Bussel EF; Richard E; Busschers WB; Steyerberg EW; van Gool WA; Moll van Charante EP; Hoevenaar-Blom MP
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1145-1152. PubMed ID: 31294917
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
